Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

We investigated whether treatment with LDE-paclitaxel changes plaque progression by coronary CT angiography and is safe in patients with chronic coronary artery disease. Clinical and laboratory safety evaluations were made at baseline and every 3 weeks until the end of the study.

Coronary Artery Disease 59

Coronary Artery Disease Laboratory Plaque Biomarkers 59

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2024

Receiver operating characteristic curves were used to determine the best cut-off values of clinical and laboratory data for predicting myocardial injury. The stratified log-rank statistic was used to compare the probability of patients developing intensive care.

Risk Factors 64

Risk Factors Laboratory Cerebrovascular Disease Coronary Artery Disease 64

Circulation

JANUARY 15, 2024

It outlines the pathophysiology of CAC and reviews laboratory, histopathological, and genetic studies, as well as imaging findings, to characterize different types of calcification and to elucidate their implications. This review summarizes the current understanding and literature on CAC.

Coronary Artery Disease 45

Coronary Artery Disease Atherosclerosis Laboratory Plaque 45

Dr. Paddy Barrett

AUGUST 22, 2023

Subscribe now APOE4 & Cardiovascular Risk We now know that carriers of APOE4 typically have higher circulating APOB levels, but the question is how much this influences the risk of cardiovascular disease. The association of apolipoprotein-E ( APOE ) gene polymorphisms with coronary artery disease: a systematic review and meta-analysis.

Cholesterol 52

Cholesterol Dementia Cardiovascular Disease Coronary Artery Disease 52